Feb. 19 (UPI) -- Pfizer and BioNTech said Friday they have asked federal regulators for clearance to begin storing its coronavirus vaccine at warmer temperatures, which would make it easier to store and ship.
The companies, which partnered to develop the COVID-19 vaccine, said they have asked the Food and Drug Administration for approval.